Skip to main content
  • Sign in
  • Help
BOPA
  • Why join BOPA
  • Pricing
  • Education
    • BOPA Introduction to Cancer Course London 2026
    • Courses and eLearning
    • SACT Verification Hub (Passport)
    • Resource Library
    • Cancer Hub
    • Education & Training Standards
    • Let’s Talk About SACT – a BOPA Podcast
  • About BOPA
    • About BOPA
    • Welcome to BOPA
    • Executive Committee
    • Subcommittees
    • Affiliated Groups
    • Cancer Advisory Groups & Specialist Interest Groups
    • International Groups
    • BOPA Fellows
    • Corporate Membership
    • BOPA membership FAQs
  • Join Discussions
    • BOPA Forums
    • BOPA forum FAQs
  • Conference
    • Latest Conference 2026
    • Abstract Submission
    • Past Symposiums / Conferences
  • News & Events
    • UKPPLB Open Letter
    • News
    • Events calendar
    • Submit event
  • Menu iconLCC
    • LCC
    • Cancer Hub
  • Menu iconBOPA/IOCN Monographs
  • Join BOPA
Join BOPA
BOPA Join BOPA
  • Why join BOPA
  • Pricing
  • Education
    • BOPA Introduction to Cancer Course London 2026
    • Courses and eLearning
    • SACT Verification Hub (Passport)
    • Resource Library
    • Cancer Hub
    • Education & Training Standards
    • Let’s Talk About SACT – a BOPA Podcast
  • About BOPA
    • About BOPA
    • Welcome to BOPA
    • Executive Committee
    • Subcommittees
    • Affiliated Groups
    • Cancer Advisory Groups & Specialist Interest Groups
    • International Groups
    • BOPA Fellows
    • Corporate Membership
    • BOPA membership FAQs
  • Join Discussions
    • BOPA Forums
    • BOPA forum FAQs
  • Conference
    • Latest Conference 2026
    • Abstract Submission
    • Past Symposiums / Conferences
  • News & Events
    • UKPPLB Open Letter
    • News
    • Events calendar
    • Submit event
  • Menu iconLCC
    • LCC
    • Cancer Hub
  • Menu iconBOPA/IOCN Monographs
  • Join BOPA

Home » Research

Research

BOPA encourages its members to share helpful documents that can benefit other members.  BOPA respects the intellectual property of original authors and requires anyone who uses other members’ work to include an acknowledgment of, or reference to, the source in their version.

DISCLAIMER:
BOPA is not the author or owner of some of the documents published on our website.  BOPA as a professional interest group will share documents via its website that are of interest to BOPA members, but has no responsibility for use of the documents and for any recommendations within the documents so members must use these at their discretion. BOPA cannot accept responsibility for any errors or omissions or for any consequences from application of information in the documents attached and make no warranty, expressed or implicit with respect to the contents of this webpage. You must obtain professional or specialist advice before taking, or refraining from, any action on the basis of the content on our site or document(s) downloaded from it.

Posters and abstracts on the BOPA website remain the property of the authors and anyone wishing to reference or share this work must contact the authors directly. Abstracts subsequently published in JOPP follow copyright rules from JOPP.

Last reviewed: 09/02/23 by Sophie Harding

Non-medical prescribers (NMP) opinions and beliefs concerning non-medical prescribing current practice within oncology

Abstracts

View resources
Last reviewed: 09/02/23 by Sophie Harding

Opinions of medical prescribers (NMP) and senior managers concerning non-medical prescribing practice in oncology

Abstracts

View resources
Last reviewed: 10/07/19 by Andrea Preston

Overweight lymphoma patients treated by actual body weight had no excess of chemotherapy toxicity: Experience from two large trials

Abstracts

View resources
Last reviewed: 10/07/19 by Dr. Shereen Nabhani-Gebara

Perceptions of Oncology Pharmacists about their Visibility to Patients

Abstracts

View resources
Last reviewed: 10/07/19 by Katherine Bayliss

Pilot study: Response rates and incidence of neutropenia in metastatic colorectal patients receiving Lonsurf® (trifluridine-tipiracil)

Abstracts

View resources
Last reviewed: 10/07/19 by Emma Dunlop Corcoran

Quality of life in patients receiving medicines for prostate cancer: What do clinicians think is important?

Abstracts

View resources
Last reviewed: 17/03/21 by Dr. Shon Crampton

Stability of ABP 980, a Trastuzumab biosimilar, after reconstitution of lyophilized drug product

Abstracts

View resources
Last reviewed: 10/07/19 by Dr. Hector Mateo-Carrasco

Infliximab v adalimumab v vedolizumab in immunotherapy-related colitis: an efficacy comparison using indirect methods

Abstracts

View resources
Last reviewed: 10/07/19 by Dushyanthi Udeshika Sembukutti Arachchige

Knowledge, attitudes and practice of Oncology Pharmacists, handling cytotoxic anti-cancer drugs in oncology units of government hospitals, Sri Lanka.

Abstracts

View resources
Last reviewed: 10/07/19 by Dr. Hector Mateo-Carrasco

Management of oncological skin ulcers with topical sevoflurane: a case series

Abstracts

View resources
Last reviewed: 10/07/19 by Dr. Hector Mateo-Carrasco

New oral therapies in breast cancer: an efficacy comparison using Bayesian network meta-analysis

Abstracts

View resources
Last reviewed: 10/07/19 by Kelly Baillie

“Real World” populations compared to clinical trials: Can electronic record linkage be used to identifiy trial eligible patients?

Abstracts

View resources

Filter for resources

  • Types

  • Tags

  • Reset

Previous 1 … 19 20 21 Next
BOPA logo
  • Why join BOPA
  • Pricing/Join
  • Latest Conference 2026
  • Education
  • About
  • News & Events
  • Help
  • Go to LinkedIn
  • Go to Facebook
  • Go to Instagram
  • Go to Bluesky

© Copyright 2026 British Oncology Pharmacy Association.
Registered Charity No. 1065026

  • Privacy Policy
  • T&Cs Website
  • T&Cs Membership
  • Cookies
  • Contact
Designed and developed by Rouge
Our website uses cookies to distinguish you from other users of our website. This helps us to provide you with a good experience when you browse our website and also allows us to improve our site. By continuing to browse the site, you are agreeing to our use of cookies.